Last updated 2026-07-20
- Raised $3M Series A led by VLX Ventures, Apr 2018
- Raised $600k Seed round led by VLX Ventures, Nov 2013
Total raised
$3.6M
Last: Undisclosed Round 2018-05
Stage
Series A
Founded
2014
Headcount
7
HQ
Tel Aviv, Israel
Sector
Health Tech & Life Sciences
About
Eximore is a biopharmaceutical platform company focused on designing innovative solutions for the ophthalmological community. The company has developed a non-invasive patented punctal plug drug delivery system that uses nano-particle technology to mold active drug into the plug itself, providing sustained release of medication. This integrated “Pack & Release” delivery system aims to increase patient compliance, optimize consistent dosing, and improve patient outcomes for chronic conditions such as glaucoma and dry eye syndrome.
Funding history · 2 rounds · $3.6M total
2018-04
A Round
$3.0M
★ VLX Ventures★ Rimonci Capital★ Docor International Management
2013-11
Seed
$600K
★ VLX Ventures★ Xenia Venture Capital
Headcount over time
From 3 (2015-06) to 8 (2023-05) · +5 (+167%) · 4 points · source: Finder history + radar grounding
Q&A
- What is Eximore's primary focus?
- Eximore is developing ophthalmic drug-delivery products, specifically a noninvasive punctal plug designed to release glaucoma drugs over a long period to improve patient compliance.
- Where is Eximore headquartered?
- Eximore is headquartered in Shoham, Israel.
- When was Eximore founded?
- Eximore was founded in November 2013.
- What is Eximore's current employee count?
- Eximore has 3 employees, falling within the 1-10 employee bucket.
- What is Eximore's total funding raised to date?
- Eximore has raised a total of $3,600,000 USD.
- When was Eximore's most recent funding round and who were the investors?
- Eximore's most recent funding round occurred in May 2018, with investments from VLX Ventures and Rimonci Capital.
- What is Eximore's primary sector classification?
- Eximore's primary sector is Health Tech & Life Sciences.
Team · 2
Eyal Sheetrit
Founder · Co-Founder & CEO
Guy Ben Simon
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2CB2B
Highlights
1 PatentsVerified
Tags
bioconvergencepersonalizationnon-invasiveeye-diseasesmedical-technologiesdrug-deliveryophthalmologyglaucomamedical-devicesadherenceclinicsbiopharmaceutical
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | eximore.co.il/ |
|---|
Identifiers & details
| Legal name | Eximore Ltd |
|---|---|
| Founded | 2014 |
| Employees (exact) | 7 |
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | eximore.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514996487 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2013-11-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2022 |
| Active charges / liens | 0 |
| Registry events | 1 — other (1) |
| Registered address | קפלן 0 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-15 | עדכון חיובים במג~ק |